Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Osteoporos Int ; 21(1): 109-18, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19373426

RESUMO

UNLABELLED: In comparison with hip fractures, increased expression of genes in the Wnt pathway and increased Wnt activity were found in bone samples and osteoblast cultures from patients with osteoarthritis, suggesting the involvement of this pathway in subchondral bone changes. No consistent differences were found in the genetic association study. INTRODUCTION: This study aims to explore the allelic variations and expression of Wnt pathway genes in patients with osteoporosis and osteoarthritis. METHODS: The expression of 86 genes was studied in bone samples and osteoblast primary cultures from patients with hip fractures and hip or knee osteoarthritis. The Wnt-related activity was assessed by measuring AXIN2 and in transfection experiments. Fifty-five SNPs of the LRP5, LRP6, FRZB, and SOST genes were analyzed in 1,128 patients. RESULTS: Several genes were differentially expressed in bone tissue, with the lowest values usually found in hip fracture and the highest in knee osteoarthritis. Overall, seven genes were consistently upregulated both in tissue samples and in cell cultures from patients with knee osteoarthritis (BCL9, FZD5, DVL2, EP300, FRZB, LRP5, and TCF7L1). The increased expression of AXIN2 and experiments of transient transfection of osteoblasts with the TOP-Flash construct confirmed the activation of Wnt signaling. Three SNPs of the LRP5 gene and one in the LRP6 gene showed marginally significant differences in allelic frequencies across the patient groups, but they did not resist multiple-test adjustment. CONCLUSIONS: Genes in the Wnt pathway are upregulated in the osteoarthritic bone, suggesting their involvement not only in cartilage distortion but also in subchondral bone changes.


Assuntos
Osteoartrite/genética , Osteoporose/genética , Proteínas Wnt/genética , Idoso , Idoso de 80 Anos ou mais , Células Cultivadas , Feminino , Frequência do Gene , Estudos de Associação Genética/métodos , Predisposição Genética para Doença , Genótipo , Fraturas do Quadril/genética , Fraturas do Quadril/metabolismo , Humanos , Masculino , Osteoartrite/metabolismo , Osteoartrite do Quadril/genética , Osteoartrite do Quadril/metabolismo , Osteoartrite do Joelho/genética , Osteoartrite do Joelho/metabolismo , Osteoblastos/metabolismo , Osteoporose/metabolismo , Polimorfismo de Nucleotídeo Único , Transdução de Sinais/genética , Regulação para Cima , Proteínas Wnt/metabolismo
2.
J Clin Epidemiol ; 49(2): 255-61, 1996 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8606328

RESUMO

To characterize and compare the toxicity profiles of aspirin and acetaminophen when used by large populations, all records of adverse drug reactions to these drugs reported to the Spanish Drug Monitoring System from 1982 to 1991 were analyzed. According to these data, aspirin-induced reactions were more serious than those reactions to acetaminophen; the severity of all the reactions in both cases was associated with time of exposure and with the accumulated dose administered. For GI reactions to aspirin no association was found between severity and time of exposure or dose, although an association with age was found. There were no differences between the proportions of deaths, malformations, and renal damage recorded for either of the two groups. Proportions of hematological and hepatic disturbances were greater with acetaminophen. Adverse drug reaction data for aspirin and acetaminophen from spontaneous reporting seem to be consistent with data coming from observational studies.


Assuntos
Acetaminofen/efeitos adversos , Sistemas de Notificação de Reações Adversas a Medicamentos , Aspirina/efeitos adversos , Adolescente , Adulto , Sistemas de Notificação de Reações Adversas a Medicamentos/tendências , Distribuição por Idade , Idoso , Causas de Morte , Criança , Pré-Escolar , Coleta de Dados , Medicina de Família e Comunidade , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Espanha/epidemiologia
3.
Artigo em Espanhol | MEDLINE | ID: mdl-7484303

RESUMO

Data from 62 schizophrenic patients (DSM III), aged 18 to 30, who were treated in the public medical system, and showed a relapse in 1987, after an one-year-follow up, were analyzed. It was observed that cannabis and alcohol use increased the probability of a relapse of schizophrenia in the follow-up period, whilst moderate alcohol use (less than 70 cc of pure alcohol/day) had no influence in the probability of relapse.


Assuntos
Cannabis , Etanol , Esquizofrenia/complicações , Transtornos Relacionados ao Uso de Substâncias/complicações , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Adolescente , Adulto , Feminino , Humanos , Masculino , Prognóstico , Estudos Prospectivos , Escalas de Graduação Psiquiátrica , Recidiva , Esquizofrenia/diagnóstico
4.
Br J Psychiatry ; 164(5): 679-81, 1994 May.
Artigo em Inglês | MEDLINE | ID: mdl-7921721

RESUMO

Data were analysed from 62 schizophrenic patients between 18 and 30 years of age, treated at the community mental health centres in Navarra, who had relapsed and then completed a one-year follow-up study. Factors influencing the course of illness during follow-up were: continuing cannabis consumption; previous cannabis intake; non-compliance with treatment; and stress.


Assuntos
Abuso de Maconha/epidemiologia , Esquizofrenia/epidemiologia , Psicologia do Esquizofrênico , Adolescente , Adulto , Comorbidade , Dronabinol/efeitos adversos , Feminino , Seguimentos , Humanos , Masculino , Abuso de Maconha/psicologia , Abuso de Maconha/reabilitação , Cooperação do Paciente/psicologia , Recidiva , Esquizofrenia/reabilitação , Estresse Psicológico/complicações , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...